Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NAP1L1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | SF3B3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | INPP5B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | DDX31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | PMFBP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | NAA25 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | CREBRF | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
mRNA | B4GALT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | USF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | PCDHGA11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |